Literature DB >> 6704011

Improving the therapeutic index of topically applied ocular drugs.

T J Zimmerman, K S Kooner, A S Kandarakis, L P Ziegler.   

Abstract

Nasolacrimal occlusion (NLO) and eyelid closure are simple techniques that not only increase the ocular bioavailability of topically applied ocular drugs but also reduce the probability of adverse systemic effects. Each serves to improve the therapeutic index. Subsequent to the application of 0.5% timolol maleate, the effects of NLO and eyelid closure were compared with the effects of no procedures. In this experiment, systemic drug absorption in normal volunteers was reduced more than 60%. Measurements were made by radioimmunoassay of timolol in blood plasma. In addition, the diminution of fluorescein in the anterior chamber was observed for three hours following direct application to the lower cul-de-sac. Results indicate a lower fluorescein concentration and a shorter duration of fluorescence in the absence of either experimental technique. Both NLO and eyelid closure seem to be safe, simple, and effective procedures that could minimize dosage requirements, as well as side effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704011     DOI: 10.1001/archopht.1984.01040030429017

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  36 in total

1.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

2.  'This added to my multiple myopia'.

Authors:  Les Irwig
Journal:  BMJ       Date:  2003-06-14

3.  Effect on mydriasis of modifying the volume of phenylephrine drops.

Authors:  E W Craig; P G Griffiths
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

Review 4.  Chronic open-angle glaucoma. Review for primary care physicians.

Authors:  Feisal A Adatia; Karim F Damji
Journal:  Can Fam Physician       Date:  2005-09       Impact factor: 3.275

5.  Topical brinzolamide and metabolic acidosis.

Authors:  G J Menon; S A Vernon
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 6.  Medical treatment of glaucoma--a reappraisal of the risks.

Authors:  P Diggory; W Franks
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

7.  Tensioactivity and supramolecular organization of the palmitoyl prodrug of timolol.

Authors:  B Pech; J E Proust; Y Bouligand; J P Benoit
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

Review 8.  Topical medication instillation techniques for glaucoma.

Authors:  Li Xu; Xuemei Wang; Meijing Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

9.  Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.

Authors:  James Brian McAlvin; Changyou Zhan; Jenny C Dohlman; Paraskevi E Kolovou; Borja Salvador-Culla; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

10.  Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system.

Authors:  Junji Narioka; Yuichi Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.